Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Stock Transaction
SEC Form 4 Filing
Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting of restricted stock units and subsequent acquisition of Class A Common Stock.
Summary
- On June 20, 2024, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., reported a transaction involving restricted stock units (RSUs).
- 31,000 RSUs vested, converting into 31,000 shares of Class A Common Stock.
- Following the transaction, Singleton directly owns 94,114 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company executives.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects an increase in the executive's holdings, aligning their interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of transaction: vesting of restricted stock units and acquisition of Class A Common Stock. |
| 06/24/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.